ALMS
Alumis is a biotechnology company focused on developing therapies for immune-mediated diseases. Based in the San Francisco Bay Area, it advances a late-stage portfolio of targeted, precision therapeutics designed to improve patient outcomes across conditions such as lupus and psoriasis. The company emphasizes integrating scientific insights with a proprietary data analytics platform to accelerate therapeutic development. Alumis’ leadership and operations are anchored in South San Francisco, California.
No recent deals for this company.